Clinical Trial Update: Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 trial evaluating cytotoxic T-lymphocytes as a prophylaxis against cytomegalovirus infection in patients followin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Cytomegalovirus-specific cytotoxic T lymphocytes (cytotoxic T lymphocytes)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Cytomegalovirus Infections | Phase 1 | Status: COMPLETED